XML 52 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity (Details 5)
 3 Months Ended 5 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares, Outstanding at beginning of year 100,137  
Shares, Outstanding at end of year 764,137 100,137
Warrant [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares, Outstanding at beginning of year 350,000 0
Shares, Granted 1,280,000 350,000
Shares, Exercised 0 0
Shares, Forfeited 0 0
Shares, Outstanding at end of year 1,630,000 350,000
Shares, Vested and expected to vest 1,100,000 239,000
Shares, Exercisable 0 0
Weighted-Average Exercise Price, Outstanding at beginning of year | $ / shares $ 1.05 $ 0
Weighted-Average Exercise Price, Granted | $ / shares 1.11 1.05
Weighted-Average Exercise Price, Exercised | $ / shares 0 0
Weighted-Average Exercise Price, Forfeited | $ / shares 0 0
Weighted-Average Exercise Price, Outstanding at end of year | $ / shares 1.10 1.05
Weighted-Average Exercise Price, Vested and expected to vest | $ / shares 1.10 1.05
Weighted-Average Exercise Price, Exercisable | $ / shares $ 0 $ 0
Weighted Average Remaining Contractual Life, Granted 4 years 9 months 25 days 4 years 11 months 23 days
Weighted Average Remaining Contractual Life, at end of year 4 years 9 months 14 days 4 years 11 months 23 days
Weighted Average Remaining Contractual Life, Vested and expected to vest 4 years 9 months 14 days 4 years 11 months 23 days
Weighted Average Remaining Contractual Life, Exercisable 0 years  
Average Intrinsic Value, Outstanding, at end of year | $ $ 0 $ 0
Average Intrinsic Value, Vested and expected to vest | $ 0 0
Average Intrinsic Value, Exercisable | $ $ 0 $ 0